<html>
<head>
<title>Revista Matéria</title>
</head>
<body>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Cytocompatibility 
  evaluation of hydroxyapatite/collagen composites doped with Zn<sup>+2</sup> 
  </b></font></p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>Avaliação da 
  citocompatibilidade dos compósitos hidroxiapatita/colágeno dopados com Zn<sup>+2</sup></b></font></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Maria Helena 
  Santos<sup>I</sup>; Ana Paula M. Shaimberg<sup>II</sup>; Patricia Valerio<sup>II</sup>; 
  Alfredo M. Goes<sup>II</sup>; Maria de Fátima Leite<sup>II</sup>; Herman S. 
  Mansur</b><sup><b>III</b></sup></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Department 
  of Dentistry, Federal University of Vales do Jequitinhonha e Mucuri. FCSB/UFVJM, 
  CP 38, CEP 39100-000, Diamantina, Minas Gerais, Brazil. e-mail: <a href="mailto:mariahelena.santos@gmail.com"> 
  mariahelena.santos@gmail.com</a><br>
  <sup>II</sup>Department of Biochemistry and Immunology, Federal University of 
  Minas Gerais. ICB/UFMG, Belo Horizonte, Minas Gerais, Brazil. e-mail: 
   <a target="_blank" href="mailto:muchon@terra.com.br"> 
  muchon@terra.com.br</a>, <a target="_blank" href="mailto:patricia.valerio@terra.com.br"> 
  patricia.valerio@terra.com.br</a>, <a target="_blank" href="mailto:goes@icb.ufmg.br"> 
  goes@icb.ufmg.br</a>, <a target="_blank" href="mailto:leitemd@dedalus.lcc.ufmg.br"> 
  leitemd@dedalus.lcc.ufmg.br</a><br>
  <sup>III</sup>Department of Metallurgical and Materials Engineering, Federal 
  University of Minas Gerais, EE/UFMG, Belo Horizonte, Minas Gerais, Brazil. e-mail: 
  <a href="mailto:hmansur@uol.com.br"> 
  hmansur@uol.com.br</a></font></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<hr 1 size="1" noshade>
<p> <font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b> ABSTRACT </b> 
  </font></p>
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">The cytocompatibility 
  of synthetic hydroxyapatite/collagen composites alone or doped with Zn<sup>+2</sup> 
  was tested by using primary culture of osteoblasts. The hydroxyapatite (HAP) 
  was synthesized having calcium hydroxide and orthophosphoric acid as precursors. 
  A new HAP composite was developed adding 1.05 w% of Zn(NO<sub>3</sub>)<sub>2</sub>.6H<sub>2</sub>O 
  forming HAPZn. The pure type I collagen (COL) was obtained from bovine pericardium 
  by enzymatic digestion method. The HAP/COL and HAPZn/COL composites were developed 
  and characterized by SEM/EDS. The cell viability and alkaline phosphatase activity 
  in the presence of composites were evaluated by MTT assay and NBT-BCIP assay, 
  respectively, and compared to osteoblastic cells of the control. Three individual 
  experiments were accomplished in triplicates and submitted to the variance analysis 
  and Bonferroni’s post-test with statistically significant at p&lt;0.05. The 
  HAPZn/COL composite did not stimulate the proliferation and increasing of alkaline 
  phosphatase activity of the osteoblastic cells. The tested composites did not 
  alter the cellular viability neither caused alterations in the cellular morphology 
  in 72 h showing adequate properties for biological applications.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&nbsp;<b>Keywords: 
  </b> Biomaterials, hydroxyapatite, collagen, cytocompatibility, zinc. </font> 
</p>
<hr 1 size="1" noshade>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b>&nbsp;</font></p>
<p> <font size="2" face="Verdana, Arial, Helvetica, sans-serif">A citocompatibilidade 
  de compósitos sintéticos hidroxiapatita/colágeno dopados ou não com Zn<sup>+2</sup> 
  foi avaliada, usando cultura primária de osteoblastos. A hidroxiapatita (HAP) 
  foi sintetizada tendo como precursores o hidróxido de cálcio e o ácido ortofosfórico. 
  Um novo compósito de HAP foi desenvolvido adicionando 1,05% em peso de Zn(NO<sub>3</sub>)<sub>2</sub>.6H<sub>2</sub>O, 
  obtendo-se HAPZn. Colágeno tipo I puro (COL) foi obtido de pericárdio bovino 
  pelo método da digestão enzimática. Os compósitos HAP/COL e HAPZn/COL foram 
  desenvolvidos e caracterizados através de MEV/EDS. A viabilidade celular e a 
  produção de fosfatase alcalina na presença dos compósitos foram avaliadas pelos 
  ensaios de MTT e NBT-BCIP, respectivamente, e comparadas às células osteoblásticas 
  do controle. Três experimentos individuais foram realizados em triplicatas e 
  submetidos à análise de variância e pós-teste de Bonferroni com significância 
  estatística p&lt;0,05. Os compósitos HAPZn/COL não estimularam a proliferação 
  e o aumento da produção de fosfatase alcalina das células osteoblásticas. Os 
  compósitos testados não alteraram a viabilidade celular nem causaram alterações 
  na morfologia celular em 72 h, mostrando propriedades adequadas para aplicações 
  biológicas.</font></p>
<p> <font face="Verdana, Arial, Helvetica, sans-serif" size="2"> <b>&nbsp;Palavras-chave:</b> 
  Biomateriais, hidroxiapatita, colágeno, citocompatibilidade, zinco.</font></p>
<hr 1 size="1" noshade>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>1 INTRODUCTION</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Biodegradable polymers 
  and bioactive ceramics are being combined in a variety of composite materials 
  for tissue engineering scaffolds &#91;1&#93; with the objective of substitution and 
  regeneration of hard tissues. Calcium phosphates (CaP)/collagen composites have 
  been developed due to its similar composition with the bone tissue &#91;2-4&#93;. The 
  main advantageous in collagen load with hydroxyapatite is the modulation of 
  the adhesion process to osteoprogenitor cells migrate and differentiate in substratum 
  &#91;5&#93;. &nbsp; </font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Research groups 
  have studied how to find biomaterials and techniques to impart appropriate biological 
  properties to synthetic composites for replacement of the human skeleton. Zinc 
  is an essential trace element with stimulatory effects on osteoblastic cell 
  proliferation and bone formation <i>in vitro</i> and <i>in vivo</i>. It hold 
  an inhibitory effect on osteoclastic bone resorption &#91;6, 7&#93;. Several researchers 
  have attempted to doper materials with Zn<sup>+2</sup> at low concentrations 
  increasing the bioactivity of bone cells &#91;4, 6-8&#93; and decreasing and regulating 
  the inflammatory reaction &#91;9&#93;.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Evaluation of the 
  citocompatibility of the composite is usually performed via <i>in vitro</i> 
  citotoxicity test. It is a sensitive and reproducible screening method to detect 
  cell death or other effects on cellular functions. The primary culture osteoblasts 
  is a well established model to investigate biocompatibility evaluating the cellular 
  viability due its proliferated capacity &#91;8, 10, 11&#93;. </font> </p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The present <i>in 
  vitro</i> study developed hydroxyapatite/collagen composites doped with Zn<sup>+2</sup> 
  to attempt the materials association with adequate properties for biological 
  applications in the recovery of the bone tissue by trauma or pathogenies.</font></p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b> 2 MATERIAL 
  AND METHODS</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Hydroxyapatite 
  (HAP) was synthesized having calcium hydroxide and orthophosphoric acid as precursors 
  &#91;12&#93;. A new composite of HAP was developed adding 1.05 w% of Zn(NO<sub>3</sub>)<sub>2</sub>.6H<sub>2</sub>O 
  during the synthesis obtaining HAPZn &#91;4&#93;. The pure type I collagen (COL) was 
  obtained from bovine pericardium by enzymatic digestion method &#91;13&#93;. The composites 
  HAP/COL and HAPZn/COL were developed with the ratio 80/20 (CaP/COL, weight %) 
  &#91;4&#93;.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The materials were 
  covered with a fine layer of gold (Au) and the morphology and semi-quantitative 
  elementary analysis of the sample microareas were obtained by X-ray energy dispersive 
  spectroscopy (EDS) and scanning electron microscopy (SEM) thought JSM model 
  6360LV - JEOL equipment, using 10 to 15 KeV. The results were determined for 
  the analysis of three different areas from each sample. </font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>2.1 Culture 
  of Osteoblasts</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Osteoblasts were 
  isolated from the calvaria of 1-5 days old Wistar rats by enzymatic digestio 
  method &#91;14&#93;. Briefly, after cut into small pieces, the calvaria bone was digested 
  with 1% trypsin and four times with 2% collagenase. The supernatant of the three 
  last washes were centrifuged 1000xg for 5 min and the pellet was ressuspended 
  in 5 mL of RPMI-1640 (Sigma, St Louis, USA) medium supplement with 10% fetal 
  bovine serum (FBS) (GibcoBRL, NY, USA) and 1% antibiotic-antimycotic solution 
  (GibcoBRL, NY, USA). After confluence the cells were replicated and used on 
  passage 2. </font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Osteoblasts were 
  plated at the density 1 x 10<sup>5</sup> cells and incubated with granules of 
  the different composites. The same culture medium containing osteoblasts without 
  the presence of the composites was use as a negative control. The experiments 
  were performed 72 h after incubation.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&nbsp;<b>2.2  
  Cellular Viability and Alkaline Phosphatase Activity</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Osteoblast viability 
  was evaluated by MTT assay in the presence of composites. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium 
  bromide) is based on the capacity of viable cells to metabolize tetrazolium 
  to formazan crystals, a purple dye that can be solubilized and measured by optical 
  density. After incubation for 18 h the plates were measured at 595 nm.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Alkaline phosphatase 
  production of osteoblasts was analyzed by NBT-BCIP (indolylphosphate-nitroblue 
  tetrazolium) assay. Nitroblue tetrazolium is hydrolyzed by the alkaline phosphatase 
  secreted by osteoblasts and the intensity of enzyme activity was measured at 
  595 nm. The morphology of the osteoblasts in contact with the composites and 
  in the control group was observed by transmitted light microscopy and photographies 
  were obtained.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Data were analyzed 
  statistically using variance test (ANOVA) and Bonferroni’s post-test. Differences 
  were considered significant at p&lt;0.05</font></p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>3 RESULT AND 
  DISCUSSION</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Human bone is mainly 
  composed of hydroxyapatite crystals and collagen fibers. Calcium phosphate (CaP)/COL 
  composites are a biodegradable artificial bone developed to engineer the organized 
  bone structure, mimicking the biological conditions &#91;5&#93;. These composites are 
  considered one of the most promising biomaterials to replace autologous bones 
  due to structural and biological similarity to this tissue and excellent biocompatibility 
  &#91;1, 3, 5&#93;. The composite development is one alternative that is being considered 
  and studied to combine the typical bioactive behavior and mechanical properties 
  such as elastic modulus and toughness of some materials and to produce composites 
  with properties closer to bone tissue &#91;3, 5&#93;.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The morphology 
  and semi-quantitative composition of present chemical elements in the HAP/COL 
  sample can be observed in <a href="/img/revistas/rmat/v12n2/a08fig01.gif">Fig. 1</a>. The scanning 
  electron micrograph (SEM) of HAP/COL surface showing a homogeneous aspect with 
  HAP particles into COL matrix (<a href="/img/revistas/rmat/v12n2/a08fig01.gif">Fig. 1A</a>) and 
  the energy dispersive spectroscopy (EDS) showing peaks of high intensity of 
  Ca, P and C, and residual elements of its synthesis, Na and Cl (<a href="/img/revistas/rmat/v12n2/a08fig01.gif">Fig. 
  1B</a>). The qualitative chemical composition of the composites showed similar 
  characteristics to their constituent materials.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The composites 
  tested by MTT assay showed no significant differences in absorbance when compared 
  with the control (<i>p</i>&gt;0.05). The cell viability in composites doped 
  with Zn<sup>+2</sup> (HAPZn/COL) or undoped (HAP/COL) showed no difference (<a href="/img/revistas/rmat/v12n2/a08fig02.gif">Fig. 
  2</a>). </font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The alkaline phosphatase 
  production (<a href="/img/revistas/rmat/v12n2/a08fig03.gif">Fig. 3</a>) of the osteoblasts in 
  presence of the Zn<sup>+2</sup> doped and undoped composites was comparable 
  to alkaline phosphatase production of the control cells. The osteoblasts in 
  contact with HAPZn/COL and HAP/COL composites produced alkaline phosphatase 
  comparable to control cells. </font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The presence of 
  Zn<sup>+2</sup> in low concentrations can induce a greater metabolization and 
  can produce a greater alkaline phosphatase production of the osteoblasts. The 
  literature studies related that zinc released from the ZnCaP stimulates osteoblastic 
  activities &#91;6, 7, 9&#93;. Nevertheless, zinc is known as a potent inhibitor 
  of the crystal growth of apatite, which is a controversial issue. Sogo <i>et 
  al</i>., 2004, reported that cytocompatibility test using preosteoblastic of 
  mouse calvaria showed no significant differences between pure <font face="Symbol">a</font>TCP 
  and <font face="Symbol">a</font>ZnTCP with a zinc content of 0.11 wt%. Webster 
  <i>et al</i>., 2004, reported that the adhesion of human osteoblasts was greater 
  on HA doped with Zn+2 than undoped HA. Kawamura <i>et al</i>., 2003 related 
  that the optimum content of zinc was found to be 0.316 wt% in the composite 
  ceramic of <font face="Symbol">b</font>ZnTCP and hydroxyapatite (HA) for promoting 
  bone formation <i>in vivo</i>, and a zinc content of 0.63 wt% was excessive 
  for both ceramics.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">In this study, 
  the result showed no significant difference between the experimental groups. 
  A zinc amount of 1.05 w% in the HAP materials did not indicate an efficient 
  content of this divalent metal to stimulate effects on proliferation and increasing 
  of alkaline phosphatase activity of the bone cells in the presence of HAPZn/COL 
  composite. Probably, the amount of the dopant Zn<sup>+2</sup> 1.05 wt% in HAPZn 
  was insufficient just after mixed with the collagen during the synthesis of 
  the HAPZn/COL composite. Thus, the tested composites did not promote this effective 
  stimulation.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Osteoblasts in 
  direct contact with the HAP/COL (<a href="/img/revistas/rmat/v12n2/html/a08fig04.htm#fig4ab">Fig. 
  4A</a>) and HAPZn/COL (HAPZn/COL (<a href="/img/revistas/rmat/v12n2/html/a08fig04.htm#fig4ab">Fig. 
  4B</a>) composites showed typical morphology and produced alkaline phosphatase 
  comparable to the control cells (<a href="/img/revistas/rmat/v12n2/html/a08fig04.htm#fig4c">Fig. 
  4C</a>). </font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Osteoblastic cells 
  are the basic structural and functional units in bone growth and metabolism 
  and its behavior in the presence of materials is a suitable experimental model 
  for biocompatibility evaluation &#91;7&#93;. The osteoblasts produced free alkaline 
  phosphatase in the matrix that was colored by BCIP-NBT. Only normal osteoblastic 
  cells can metabolize and transform the tetrazolium salt in blue crystals observed 
  in the cells (<a href="/img/revistas/rmat/v12n2/html/a08fig04.htm#fig04ab">Fig. 4</a>). This evidences 
  the presence of alkaline phosphatase already metabolized that will begin the 
  mineralization.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The doped and undoped 
  composites with a zinc content of 1.05 w% showed cytocompatibility. The osteoblasts 
  grew well in contact with the composites and showed normal morphology in 72 
  h. These findings are in accord with the literature that describe the citocompatibility 
  of Zn<sup>+2</sup> within a nontoxic level &#91;16&#93;. </font></p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>4 CONCLUSION</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The tested HAP/COL 
  composite doped with Zn+2 in amount of 1.05 w% did not stimulate effects on 
  proliferation and increasing of alkaline phosphatase activity of the osteoblastic 
  cells. The HAP/COL composites doped and undoped with Zn+2 showed acceptable 
  cytocompatibility presenting adequate properties for biological applications. 
  Further investigation is important to determine the effective amount of Zn+2 
  in these composites. </font> </p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>5 ACKNOWLEDGEMENTS</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">The authors would 
  like to thank the CAPES for financial support.</font></p>
<p>&nbsp;</p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="3"><b>6 BIBLIOGRAPHY</b></font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;1&#93; REZWAN, Q.Z., 
  CHEN, Q.Z., BLAKER, J.J., <i>et al.,</i> "Biodegradable and Bioactive Porous 
  polymer/inorganic Composite Scaffolds for Bone Tissue Engineering", <i> 
  Biomaterials</i>, v.27, pp.3413-3431, 2006.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;2&#93; BET, M.R., 
  "Preparação e Caracterização de Biocerâmicas Compostas de Colágeno e sais 
  de Fosfato de Cálcio", <i>Dissertação de Mestrado</i>, Instituto de Química 
  de São Carlos, São Carlos, 1995.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;3&#93; KIKUCHI, M., 
  IKOMA, T., ITOH, S., <i>et al., </i>"Biomimetic Synthesis of bonelike Nanocomposites 
  using the Selforganization Mechanism of Hydroxyapatite and Collagen", <i>Composites 
  Science and Technology</i>, v. 64, pp. 819-825, 2004.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;4&#93; SANTOS, M.H., 
  "Síntese e Caracterização de Biocompósitos Fosfatos de cálcio/colágeno 
  Dopados com Zinco", <i>Tese de Doutorado</i>, Escola de Engenharia/UFMG, 
  Belo Horizonte, 2005.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;5&#93; YANNAS, I.V., 
  "Natural Materials", In: <i>Biomaterials science: an introduction 
  to materials in medicine</i>, Ratner, B.D., Hoffman, A.S., Schoen, F.J., Lemons, 
  J.E. (eds), 1 ed., San Diego, Academic Press, pp. 84-94, 1996.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;6&#93; ITO, A., OJIMA, 
  O., NAITO, H. <i>et al.,</i> "Preparation, Solubility and Cytocompatibility 
  of zinc-realising Calcium Phosphate Ceramics", <i>Journal of Biomedical 
  Materials Research</i>, v. 50, pp. 178-183, 2000.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;7&#93; WEBSTER, T.J., 
  MASSA-SCHLUETER, E.A., SMITH, J.L. <i>et al.,</i> "Osteoblast Response 
  to Hydroxyapatite Doped with Divalent and Trivalent Cations", <i>Biomaterials</i>, 
  v. 25, pp. 2111-2121, 2004.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;8&#93; SERRE, C.M., 
  PAPILLARD, M., CHAVASSIEUX, P. <i>et al., </i>"Influence of Magnesium Substitution 
  on a Collagen Apatite biomaterial on the Production of a Calcifying Matrix by 
  Human Osteoblasts", <i> Journal of Biomedicals Materials Research</i>, 
  v. 42, pp. 626-633, 1998.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;9&#93; GRANDJEAN-LAQUERRIERE, 
  A., LAQUERRIERE, P., JALLOT, E. <i>et al.,</i> "Influence of the Zinc Concentration 
  of sol-gel Derived Zinc Substituded Hydroxyapatite on Cytokine Production by 
  Human Monocytes in vitro", <i>Biomaterrials</i>, v. 27, pp. 3195-3200, 
  2006.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;10&#93; VALERIO, P., 
  PEREIRA, M.M., GOES, A.M. <i>et al., </i>"The Effect of Ionic Products 
  from Bioactive Glass Dissolution Osteoblast Proliferation and Collagen Production", 
  <i>Biomaterials</i>, v. 25, pp. 2941-2948, 2004.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;11&#93; SAMPAIO, B.V., 
  GÖLLER, G., OKTAR, F.N., <i>et al., </i>"Biocompatibity Evaluation of Three 
  Different Titanium Hydroxyapatite Composites", <i>Key Engineering Materials</i>, 
  v. 284-286, pp. 639-642, 2005.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;12&#93; SANTOS, M.H., 
  OLIVEIRA, M., SOUZA, L.F.P., <i>et al.,</i> "Synthesis Control and Characterization 
  of Hydroxyapatite Prepared by wet Precipitation Process", <i>Materials 
  Research</i>, v. 7, pp. 1-6, 2004.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;13&#93; SANTOS, M.H., 
  HENEINE, L.G.D., MANSUR, H.S., "Colágeno Bovino tipo I Purificado: Biomaterial 
  Técnica e Economicamente Factível para Aplicação na Área médico-odontológica", 
  In: <i>8º Congresso Brasileiro de Polímeros</i>, pp. 1068-1069, Águas de Lindóia-SP, 
  2005.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;14&#93; SILVER, I.A., 
  DEAS, J., ERECINSKA, M., "Interactions of Bioactive Glasses with Osteoblasts 
  in vitro: Effects of 45S5 Bioglass, and 58S and 77S Bioactive Glasses on Metabolism, 
  Intracellular ion Concentrations and Cell Viability", <i>Biomaterials</i>, 
  v. 22, pp. 175-185, 2001.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;15&#93; SOGO, Y., 
  ITO, A., KAMO, M. <i>et al., </i>"Hydrolysis and Cytocompatibility of zinc-containing 
  &#913;tricalcium Phosphate Powder", <i>Materials Science and Engineering 
  C</i>, v. 24, pp. 709-715, 2004.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;16&#93; KAWAMURA, 
  H., ITO, A., MURAMATSU, T. <i>et al., </i>"Long-term Implantation of zinc-releasing 
  Calcium Phosphate Ceramics in Rabbit Femora", <i>Journal of Biomedical 
  Materials Research</i>, v. 65 A, pp. 468-474, 2003.</font></p>
<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#91;17&#93; ITO, A., KAWAMURA, 
  H., OTSUKA, M. <i>et al.,</i> "Zinc-releasing Calcium Phosphate for Stimulating 
  Bone Formation", <i>Materials Science and Engineering C</i>, v. 22, pp. 
  21-25, 2002.</font></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Data de envio: 
  02/08/06 Data de aceite: 02/10/06</font></p>
</body>
</html>